|
Schering-Plough Corporation engages in the discovery, development, manufacture, and marketing of medical therapies and treatments primarily in the United States, Canada, and Europe. The company also markets consumer brands in the over-the-counter (OTC), foot care, and sun care markets, as well as operates a global animal health business. The company operates in three segments: Prescription Pharmaceuticals, Consumer Health Care, and Animal Health. The Prescription Pharmaceuticals segment manufactures and markets primary care products that include allergy/ respiratory, antibiotics, dermatologicals, and erectile dysfunction products, as well as specialty care products, such as anti-infectives, anti-inflammatories, oncology, acute coronary care, and other products for humans. It sells its products to hospitals, certain managed care organizations, wholesale distributors, and retail pharmacists. The Consumer Health Care segment manufactures and markets OTC, foot care, and sun care products. It sells its products through wholesale and retail drug, food chain, and mass merchandiser outlets. The Animal Health segment manufactures and markets animal health products to the livestock, poultry, companion animal, and aquaculture markets. It sells its products to veterinarians, distributors, and animal producers. Schering-Plough Corporation was incorporated in 1970 and is headquartered in Kenilworth, New Jersey.
|
